UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by ‘Rete Ematologica Pugliese’

Annals of hematology, 2022-08, Vol.101 (8), p.1727-1739

2022

Volltextzugriff (PDF)

P63 BREAKTHROUGH COVID‐19 IN FULL VACCINATED PATIENTS WITH MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE OF 54 PATIENTS

HemaSphere, 2023-05, Vol.7 (S2), p.44-45

2023

Volltextzugriff (PDF)

P29: EFFECTS OF VACCINATION ON INCIDENCE AND OUTCOME OF SARS‐COV‐2 INFECTION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)

HemaSphere, 2022-04, Vol.6 (Suppl), p.26-27

2022

Volltextzugriff (PDF)

Myeloma cells suppress osteoblasts through sclerostin secretion

Blood cancer journal (New York), 2011-06, Vol.1 (6), p.e27-e27

2011

Volltextzugriff (PDF)

MORBIDITY AND MORTALITY IN LONG‐TERM SURVIVORS OF HODGKIN LYMPHOMA: A SINGLE CENTER EXPERIENCE

Hematological oncology, 2019-06, Vol.37 (S2), p.498-498

2019

Volltextzugriff (PDF)

P948: INCIDENCE AND CLINICAL OUTCOME OF SARS‐COV‐2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)

HemaSphere, 2022-06, Vol.6 (Suppl), p.838-839

2022

Volltextzugriff (PDF)

P18: DARATUMUMAB (D) PLUS BORTEZOMIB (V) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW‐UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”

HemaSphere, 2022-04, Vol.6 (Suppl), p.21-21

2022

Volltextzugriff (PDF)

P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY‐RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW‐UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”

HemaSphere, 2022-04, Vol.6 (Suppl), p.20-21

2022

Volltextzugriff (PDF)

PB2016: COMPARISON BETWEEN DRD VS KRD AS SALVAGE THERAPY FOR MULTIPLE MYELOMA PATIENTS IN FIRST RELAPSE: THE REAL LIFE EXPERIENCE OF RETE EMATOLOGICA PUGLIESE (REP)

HemaSphere, 2022-06, Vol.6 (Suppl), p.1887-1888

2022

Volltextzugriff (PDF)

“Real world” outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the “rete ematologica pugliese”

Leukemia research, 2015-03, Vol.39 (3), p.279-283

2015

Volltextzugriff (PDF)

Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma

Bone marrow transplantation (Basingstoke), 2002-02, Vol.29 (4), p.285

2002

Volltextzugriff (PDF)

Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma

Bone marrow transplantation (Basingstoke), 2002-02, Vol.29 (4), p.285-290

2002

Volltextzugriff (PDF)

A case of light chain (AL) amyloidosis associated with IgD multiple myeloma (MM): clinical features, laboratory findings and outcome

Amyloid, 2011-06, Vol.18 (Suppl. 1), p.117-118

2011

Volltextzugriff (PDF)

LIGHT/TNFSF14 as a New Biomarker of Bone Disease in Multiple Myeloma Patients Experiencing Therapeutic Regimens

Frontiers in immunology, 2018-10, Vol.9, p.2459-2459

2018

Volltextzugriff (PDF)

The chloroplast genome as a tool for exploring genetic relationships among globe artichoke, leafy cardoons and wild artichokes

Acta horticulturae, 2016 (1147), p.61-68

2016

Volltextzugriff (PDF)

The stalking of mental health professionals by patients

Psychiatric services (Washington, D.C.), 2005-02, Vol.56 (2), p.137-138

2005

Volltextzugriff (PDF)

Sarco‐Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation

Liver international, 2021-07, Vol.41 (7), p.1629-1640

2021

Volltextzugriff (PDF)

PF579 TUMOR CIRCULATING PLASMA CELLS DETECTED BY FLOW CYTOMETRIC SINGLE PLATFORM METHOD ARE RELATED TO NEGATIVE PATIENTS‘ CHARACTERISTICS IN MULTIPLE MYELOMA

HemaSphere, 2019-06, Vol.3 (S1), p.241-242

2019

Volltextzugriff (PDF)

PB2130 REAL‐WORLD ITALIAN EXPERIENCE OF POMALIDOMIDE IN RELAPSED‐REFRACTORY MYELOMA: RETROSPECTIVE MULTICENTER STUDY BY THE RETE EMATOLOGICA PUGLIESE AND BASILICATA

HemaSphere, 2019-06, Vol.3 (S1), p.959-n/a

2019

Volltextzugriff (PDF)

PF644 CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: THE REAL LIFE EXPERIENCE OF RETE EMATOLOGICA PUGLIESE (REP)

HemaSphere, 2019-06, Vol.3 (S1), p.275-276

2019

Volltextzugriff (PDF)

Association Between Trait Anxiety and Vagal Tone, Withdrawal, and Recovery

Applied psychophysiology and biofeedback, 2015-06, Vol.40 (2), p.127

2015

Volltextzugriff (PDF)

Current factors affecting the choice of psychiatry as a specialty: an Italian study

Academic psychiatry, 2003-06, Vol.27 (2), p.74-81

2003

Volltextzugriff (PDF)

Examining the Roles of Mortality Salience, Partner Gender, Self Esteem and Peer Risky Sexual Behavior in Risky Sexual Behavior among Men

2018

Volltextzugriff (PDF)

Mastocytosis

Primary care, 2016-09, Vol.43 (3), p.505-518

2016

Volltextzugriff (PDF)

1 – 25 von 235

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(177)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by ‘Rete Ematologica Pugliese’

P63 BREAKTHROUGH COVID‐19 IN FULL VACCINATED PATIENTS WITH MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE OF 54 PATIENTS

P29: EFFECTS OF VACCINATION ON INCIDENCE AND OUTCOME OF SARS‐COV‐2 INFECTION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)

Myeloma cells suppress osteoblasts through sclerostin secretion

MORBIDITY AND MORTALITY IN LONG‐TERM SURVIVORS OF HODGKIN LYMPHOMA: A SINGLE CENTER EXPERIENCE

P948: INCIDENCE AND CLINICAL OUTCOME OF SARS‐COV‐2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)

P18: DARATUMUMAB (D) PLUS BORTEZOMIB (V) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW‐UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”

P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY‐RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW‐UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”

PB2016: COMPARISON BETWEEN DRD VS KRD AS SALVAGE THERAPY FOR MULTIPLE MYELOMA PATIENTS IN FIRST RELAPSE: THE REAL LIFE EXPERIENCE OF RETE EMATOLOGICA PUGLIESE (REP)

P07 BORTEZOMIB‐MELPHALAN‐PREDNISONE (VMP) VS. LENALIDOMIDE‐DEXAMETHASONE (RD) IN REAL‐LIFE MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANT: UPDATED ANALYSIS OF THE RANDOMIZED PHASE IV REAL MM TRIAL

“Real world” outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the “rete ematologica pugliese”

Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma

Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma

A case of light chain (AL) amyloidosis associated with IgD multiple myeloma (MM): clinical features, laboratory findings and outcome

LIGHT/TNFSF14 as a New Biomarker of Bone Disease in Multiple Myeloma Patients Experiencing Therapeutic Regimens

The chloroplast genome as a tool for exploring genetic relationships among globe artichoke, leafy cardoons and wild artichokes

The stalking of mental health professionals by patients

Sarco‐Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation

PF579 TUMOR CIRCULATING PLASMA CELLS DETECTED BY FLOW CYTOMETRIC SINGLE PLATFORM METHOD ARE RELATED TO NEGATIVE PATIENTS‘ CHARACTERISTICS IN MULTIPLE MYELOMA

PB2130 REAL‐WORLD ITALIAN EXPERIENCE OF POMALIDOMIDE IN RELAPSED‐REFRACTORY MYELOMA: RETROSPECTIVE MULTICENTER STUDY BY THE RETE EMATOLOGICA PUGLIESE AND BASILICATA

PF644 CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: THE REAL LIFE EXPERIENCE OF RETE EMATOLOGICA PUGLIESE (REP)

Association Between Trait Anxiety and Vagal Tone, Withdrawal, and Recovery

Current factors affecting the choice of psychiatry as a specialty: an Italian study

Examining the Roles of Mortality Salience, Partner Gender, Self Esteem and Peer Risky Sexual Behavior in Risky Sexual Behavior among Men

Mastocytosis

Suchergebnisse filtern